Dacarbazine
Back to search| Scientific Name: | Dacarbazine |
| Brand Name: | Not Available |
| Company Owner: | Abraxis pharmaceutical products, App pharmaceuticals llc, Bedford laboratories div ben venue laboratories inc, Hospira inc, Teva parenteral medicines inc, Bayer healthcare pharmaceuticals inc |
| Mechanism Of Action | The mechanism of action is not known, but appears to exert cytotoxic effects via its action as an alkylating agent. Other theories include DNA synthesis inhibition by its action as a purine analog, and interaction with SH groups. Dacarbazine is not cell cycle-phase specific. |
| Description of the Drug: | Dacarbazine is an antineoplastic agent used to treat malignant melanoma and Hodgkin’s disease. |
| Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00851
